Back to Results

CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System BiomarKers in Multiple Sclerosis (CLOCK-MS)

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Treatment

Locations

Brain Imaging Center (BIC)
University of Colorado Hospital

Principal Investigator
Enrique Alvarez

Enrique Alvarez

Study ID

Protocol Number: 19-1980

More information available at ClinicalTrials.gov: NCT03963375

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers